These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15622492)

  • 1. Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension.
    Halank M; Marx C; Miehlke S; Hoeffken G
    J Gastroenterol; 2004 Dec; 39(12):1222-3. PubMed ID: 15622492
    [No Abstract]   [Full Text] [Related]  

  • 2. Aerosolized iloprost for primary pulmonary hypertension.
    Ewert R; Wensel R; Opitz CF
    N Engl J Med; 2000 Nov; 343(19):1421-2. PubMed ID: 11183891
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
    Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized iloprost as a bridge to lung transplantation in a patient with cystic fibrosis and pulmonary hypertension.
    Tissières P; Nicod L; Barazzone-Argiroffo C; Rimensberger PC; Beghetti M
    Ann Thorac Surg; 2004 Sep; 78(3):e48-50. PubMed ID: 15337084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension.
    Minder S; Fischler M; Muellhaupt B; Zalunardo MP; Jenni R; Clavien PA; Speich R
    Eur Respir J; 2004 Oct; 24(4):703-7. PubMed ID: 15459152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T; Eberle B; Guth S; Mayer E
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute resynchronization with inhaled iloprost in a pregnant woman with idiopathic pulmonary artery hypertension.
    Cotrim C; Simões O; Loureiro MJ; Cordeiro P; Miranda R; Silva C; Avillez T; Carrageta M
    Rev Port Cardiol; 2006 May; 25(5):529-33. PubMed ID: 16910160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
    Hoeper MM; Seyfarth HJ; Hoeffken G; Wirtz H; Spiekerkoetter E; Pletz MW; Welte T; Halank M
    Eur Respir J; 2007 Dec; 30(6):1096-102. PubMed ID: 17652314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled iloprost in lung transplantation: can it avoid extracorporeal circulation in patients with severe pulmonary hypertension?
    Winterhalter M; Simon A; Fischer S; Gras C; Zuk J; Piepenbrock S; Strüber M
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):716-8. PubMed ID: 17023296
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic pulmonary arterial hypertension and inhaled iloprost: good night rebound effects?
    Domenighetti GM
    Respiration; 2007; 74(5):496-7. PubMed ID: 17671405
    [No Abstract]   [Full Text] [Related]  

  • 13. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
    Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166
    [No Abstract]   [Full Text] [Related]  

  • 14. Aerosolized prostacyclins.
    Siobal M
    Respir Care; 2004 Jun; 49(6):640-52. PubMed ID: 15165299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized iloprost customized for the critically ill.
    Harris KW; O'Riordan TG; Smaldone GC
    Respir Care; 2007 Nov; 52(11):1507-9. PubMed ID: 17971254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe pulmonary hypertension with inhaled iloprost.
    Leuchte HH; Baumgartner RA; Behr J
    Ann Intern Med; 2003 Aug; 139(4):306. PubMed ID: 12965995
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it safe to use inhaled iloprost in infants with pulmonary hypertension?
    Karaagaç AT; Yildirim AI
    Indian Pediatr; 2013 Nov; 50(11):1064-5. PubMed ID: 24382910
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
    Opitz CF; Wensel R; Winkler J; Halank M; Bruch L; Kleber FX; Höffken G; Anker SD; Negassa A; Felix SB; Hetzer R; Ewert R
    Eur Heart J; 2005 Sep; 26(18):1895-902. PubMed ID: 15888496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
    Halank M; Kolditz M; Miehlke S; Schiemanck S; Schmeisser A; Hoeffken G
    Wien Med Wochenschr; 2005 Aug; 155(15-16):376-80. PubMed ID: 16160926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.